Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | Would you like to know more about our new clinical funding scheme?
Join us on 11 September, from 10-11am to hear from Charles Swanton, our Chief Clinician; Andrew Tutt, Chair of the Clinical Research Committee; Catherine Elliot, Director of Research and Partnerships and Graham Cadwallader, Head of Clinical Research.
Whether you are a discovery, translational or clinical researcher at any career stage, this is an opportunity to ask your questions and find out how this may benefit your research. |
| | |
| | |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
| | Meet our latest grant awardees working in discovery research |
| Congratulations to the latest cohort of researchers receiving grant awards from our Discovery Research Committee:
Zoltan Takats, Burak Temelkuran, Sadaf Ghaem-Maghami, Josephine Bunch, Sergio Quezada, Alan Warren and Jessica Downs were selected for Programme Awards, whilst Paul Elliott and Sarah McClelland were awarded Programme Foundation Awards.
Kevin Marchbank, Helen Reeves, Irina Udalova and Iain McNeish received the Cancer Immunology Project Awards. Fernando Perez-Cota, Alan McIntyre, Matt Clark, Emma Harris and Kairbaan Hodivala-Dilke received Multidisciplinary Project Awards jointly funded by us and the Engineering & Physical Sciences Research Council. |
| | |
|
|
|
|
|
| | | | | In our latest research careers column, Ally Walters calls on the research community to broaden its idea of how postdocs can contribute to cancer research beyond a role as a group leader.
The skills and personal qualities possessed by a postdoc are highly desirable within many sectors. Hence, Ally calls for a cultural shift that encourages postdocs to continue to contribute to cancer research beyond academia and encourages cross-sector mobility.
Early and open conversations between postdocs and their supervisors are key to career progression. There is breadth of options open to those with a strong research background, but we need to empower postdocs to take that next step. | | |
| | | | | | | Are you eager to learn more about translating research in the brain tumour field?
Don’t miss the ‘Encourage Translation Lunch’ panel session at the upcoming Brain Tumour Conference in London.
Chaired by Tony Hickson (Cancer Research Horizons), this session brings together Petra Hamerlik (AstraZeneca), Steven Pollard (University of Edinburgh) and Juanita Lopez (The Royal Marsden Hospital).
They will discuss their experiences, perspectives and views on translating their work – from launch of a spinout company, to working with industry and leading clinical trials.
Registration closes on 9 September and there are only a few spaces left. | | |
|
|---|
|
|
|
|
| | From scientist to start-up with 3D bioprinting |
| Ishani Malhotra left her job as an industry scientist to start her own company, Carcinotech, to 3D print assay-ready, human-derived tumours for cancer drug discovery and development. She hopes these rapid, ethical and scalable alternatives to animal models will accelerate drug development and get new treatments to patients sooner.
Read her story to find out about the challenges and rewards of launching your own biotech company and why Edinburgh is a great place to do it in.
“Transitioning from a research-focused role to leading a start-up required a significant shift in mindset,” says Ishani. |
| | |
|
|
|
|
|
Deadline extended – secure your bursary to go to San Francisco |
| There’s still time to apply for a bursary up to £1500 to attend our early detection of cancer conference if you’ve submitted an abstract for a poster or lightning talk.
The final deadline is tomorrow (23 August), and the conference will take place in San Francisco between 22-24 October in a partnership between the Canary Center at Stanford, OHSU Knight Cancer Institute and us. |
| | |
|
|
|
| | | | | Our Cambridge Centre Thoracic Cancer programme and Early Cancer Institute are delighted to host the first Cambridge Symposium on Oesophageal Cancer on 7 November, taking place at the Cambridge Institute.
Register now to learn about the latest fundamental, translational and clinical advances in oesophageal cancer research from world-leaders in the field, including Rebecca Fitzgerald (University of Cambridge), Matthew Stachler (University of California San Francisco), Stuart McDonald (Barts Cancer Institute) and more.
Sign up now and submit an abstract for the chance to be selected for a lightning talk or poster prize. | | |
| | | | | | | NHS England is moving to a network of Secure Data Environments (SDEs) that streamline and vastly reduce the current ~7,000 points of data access down to 12.
If the new network is properly implemented, with more effective methods of data application and granting processes, researchers should be able to obtain the data needed for their research quicker and more efficiently.
The SDE network will consist of two parts:
- one large SDE covering the whole of England, containing high level national datasets;
- 11 smaller subnational SDEs covering areas like London or the north-east, containing more detailed datasets.
Our policy team has analysed the changes and what they mean for cancer research. | | |
|
|---|
|
|
|
|
What did you think of this email? |
|
| | |
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
